Anwar Chahal is a clinical and translational physician scientist, originally from the UK where he completed medical school, internal medicine residency (King's College) and fellowships in general cardiology, advanced imaging, and inherited cardiovascular disease (University College London and Barts Heart Centre). As part of a clinician investigator program, he also completed a PhD and AHA-funded post-doctoral fellowship investigating genomic and neural circulatory factors in sudden unexpected death in epilepsy (SUDEP) at Mayo Clinic, and Papworth, Cambridge. He trained in clinical cardiac electrophysiology at the University of Pennsylvania. In 2020, he became faculty, and, leads an independent research group, investigating cardiomyopathies, arrhythmias and sudden death syndromes, combining state-of-the-art imaging with electrophysiology, for deep phenotyping, with clinical high throughput 'omics studies. He is the founder and Medical Director of the Center for Inherited Cardiovascular Diseases and Precision Medicine, as well as Associate Professor, Consultant Cardiologist and Electrophysiologist, WellSpan Health, York, PA. He is a Research Scientist at Mayo Clinic, Rochester, MN, and Honorary Consultant with Barts Heart Centre, and Queen Mary University of London. He is the PI for The Gene Health Project, a biobank which is a collaboration with Mayo Clinic and Helix investigating gene-first screening strategies. He has active and prior funding through the AHA, NIH, Paul and Ruby Tsai Foundation, and the European Union. As an educator, he is faculty for internal medicine residency and cardiology fellowship, as well past Tutor for the Royal College of Physicians. He leads genomics education for the American Heart Association, which led to an online self-paced course: 'From Concepts to Practice: A Guide to Cardiovascular Genomics' which launched in 2023.